BioNTech Results Presentation Deck

Update on COVID-19 program - BNT162 4 ✓ Global development program established with new collaboartions with Pfizer and Fosun Pharma Four vaccine candidates selected for clinical trials following preclinical testing Ongoing Phase 1/2 clinical trials in US and Germany - first cohorts dosed Clinical trial supply from BioNTech's GMP-certified mRNA manufacturing facilities in Europe - Scale-up of BioNTech manufacturing network underway First clinical data expected in June/July 2020 BIONTECH

View entire presentation